UNSPSC 51241502: Antazoline/naphazoline

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP900. This VA Drug Class (OP900) classifies this compound as belonging to the group OPHTHALMICS, OTHER.

UNSPSC 51241502 Antazoline/naphazoline, a Commodity code, covers ophthalmic decongestants and antihistamines used in eye drops and topical preparations that state and local health departments, school districts, and public health clinics procure for treatment of allergic conjunctivitis, nasal congestion, and related conditions. The code captures pharmaceutical products formulated with antazoline or naphazoline as active ingredients, typically acquired through standing orders, cooperative purchasing agreements, or routine competitive bidding from licensed pharmaceutical wholesalers and manufacturers. State Medicaid programs, county health departments, municipal clinics, and school health services represent the primary issuing bodies, though activity under this code is modest compared to higher-volume pharmaceutical families.

The source provided contains no recent state or local contract opportunities tagged to UNSPSC 51241502, limiting visibility into current geographic concentration, specific issuing bodies, or active solicitations.